Syros Pharmaceuticals, Inc. SYRS
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.11 +0.11 +26,700.00%
After hours · Oct 30, 5:00 PM ET
0.0005 Day range 0.0005
0.0001 52-week range 0.02
- YTD
- +14.29%
- 1 year
- 0.00%
- Open
- 0.0005
- Prev close
- 0.0004
- Mkt cap
- 10.73K
- Vol
- 904
- Avg vol
- 12.67K
- EPS
- -6.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0005
- High
- 0.0005
- Forward P/E
- -0.08
- Beta
- 1.59
- Short ratio
- 0.10
- Inst. own
- 75.59%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.20
- 200-d avg
- 3.65
- 1y target
- 1.00
Analyst view
Price target (mean) 1.00
Ratings (0m) 4 0 buy · 4 hold · 0 sell
- Strong buy0
- Buy0
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.70667 | -0.81 – -0.61 | -2.22 | +68.1% | 450.00K | +16.6% | 4 |
| Next quarter | -0.70 | -0.70 – -0.70 | -0.10 | -600.0% | 0 | 0.0% | 2 |
| Current year | -1.57 | -1.67 – -1.47 | -5.72 | +72.6% | 450.00K | -95.5% | 4 |
| Next year | -2.42 | -3.14 – -1.32 | -1.57 | -54.3% | 5.00M | +1011.1% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | TD Cowen | Downgrade | Buy | Hold |
| Nov 13, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 13, 2024 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Nov 13, 2024 | Brookline Capital | Downgrade | Buy | Hold |
| Nov 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Aug 13, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Aug 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 3, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Apr 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 3, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 9, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 11, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Mar 3, 2023 | Oppenheimer | Maintained | — | Outperform |
| Mar 3, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 5, 2023 | Piper Sandler | Maintained | — | Overweight |
| Nov 15, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Nov 15, 2022 | Oppenheimer | Maintained | — | Outperform |
| Nov 15, 2022 | HC Wainwright & Co. | Maintained | — | Buy |